MACK - Merrimack Pharmaceuticals

Industry: Biotechnology Sector: Healthcare | Exchange: NASDAQ

Buy Candidate
Buy Score Rank #1597 out of #5176
Wed 26'th Jul 2017

PERIOD COVERED
2017-04-27 - 2017-07-26
CHANGE
1.47%
PRICE
$1.38
VOLUME
Sell
TREND

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

BOLLINGER
Buy
Request Prediction
0.00%

Merrimack Pharmaceuticals Stock Analysis

Technical stock analysis for Wed 26'th Jul 2017

Buy candidate since 2017-07-21 Gain 6.98%

Merrimack Pharmaceuticals gained 1.47% in the last trading day, rising from $1.36 to $1.38 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 0.73% gain for the last 2 weeks. Volume fell in the last day by -0.24 million shares, and in total, 1.22 million shares bought and sold for approximately $1.69 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

Merrimack Pharmaceuticals lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.60 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -64.23% during the next 3 months and, with 90% probability hold a price between $-0.07 and $0.57 at the end of this period.

Signals

Only positive signals in the chart today. Merrimack Pharmaceuticals holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $1.32 and $1.33. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday July 19, 2017, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Relative Strength Index (RSI)

RSI14 is 53 and the stock is currently not being overbought or oversold

Support & Resistance

Merrimack Pharmaceuticals finds support from accumulated volume at . On the upside the stock meets some resistance just above today's level from accumulated volume at $1.43, $1.63 and $1.52.

The stock is about to test the resistance from accumulated volume at $1.43 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $1.35 Price: $1.38 Resistance: $1.43
S: $1.35 Price: $1.38 R: $1.43

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.06 between high and low, or 4.51%. For the last week, the stock has had a daily average volatility of 5.77%.

Our recommended stoploss: $1.33 (-3.95%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 5 days ago.)

Overall risk:

Very Low Low Medium High Very High

Overall risk:

           

Evaluation

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate

Buy MACK Shares
Your capital is at risk.

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training
Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add MACK My Watchlist

Recommended
books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

News updates from 100+ financial publications

START FREE 5-DAY TRIAL
START FREE 5-DAY TRIAL